SCHEMBL26091050

SCHEMBL26091050

C=CCOC(=O)N1CCC(=C)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 10/20 0.44
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
SLC6A15 Q9H2J7 1/20 0.37
CYP3A4 P08684 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
MAP3K5 Q99683 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
ALDH1A1 P00352 1/20 0.34
UBE2N P61088 1/20 0.34
F10 P00742 2/20 0.33
PLG P00747 2/20 0.33
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.32
PRSS2 P07478 1/20 0.32
PRSS3 P35030 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9383271 0.83 ERN1 (0.49) ERN1LMNAMAPK1RAB9ASLC6A15
SCHEMBL21611667 0.81 DPP8 (0.37) LMNARAB9ADPP8TMEM97SIGMAR1
SCHEMBL597800 0.79 LMNA (0.45) ERN1LMNAMAPK1RAB9ASLC6A15
SCHEMBL29306874 0.79 ERN1 (0.42) ERN1LMNAMAPK1RAB9ACYP3A4
SCHEMBL6686807 0.78 ERN1 (0.51) ERN1LMNAMAPK1RAB9ASLC6A15
SCHEMBL4195614 0.74 LMNA (0.46) ERN1LMNAMAPK1RAB9ASLC6A15
SCHEMBL8833559 0.73 TSHR (0.48) ERN1LMNAMAPK1RAB9A
SCHEMBL3997516 0.73 LMNA (0.45) ERN1LMNAMAPK1RAB9ASLC6A15
SCHEMBL3992214 0.73 LMNA (0.45) ERN1LMNAMAPK1RAB9ASLC6A15
SCHEMBL10548331 0.72 ERN1 (0.40) ERN1LMNAMAPK1RAB9ASLC6A15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069547-A1 5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES, INC. (US) 2023-04-27 WO disclosed
WO-2023069547-A1 5-MEMBERED HETEROARYL CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES, INC. (US) 2023-04-27 WO disclosed